Brief Report: Dialister as a Microbial Marker of Disease Activity in Spondyloarthritis

Arthritis and Rheumatology

Volumn 69, Issue 1, 2017, Pages 114-121

  Tito, Raul Y ^a,b   Cypers, Heleen ^a   Joossens, Marie ^a,b   Varkas, Gaëlle ^a   Van Praet, Liesbet ^a   Glorieus, Elien ^c   Van den Bosch, Filip ^a   De Vos, Martine ^c   Raes, Jeroen ^a,b   Elewaut, Dirk ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; C REACTIVE PROTEIN; HLA B27 ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT; RNA 16S;

AMPLICON; ANKYLOSING SPONDYLITIS; ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE; ARTICLE; BACTEROIDETES; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; BIOCHEMICAL COMPOSITION; BODY MASS; CHRONIC INFLAMMATION; CLINICAL ARTICLE; COLON BIOPSY; COLON TISSUE; CONTROLLED STUDY; CORRELATIONAL STUDY; DIALISTER; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DYSBIOSIS; ENTERITIS; FEMALE; FIRMICUTES; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILEAL BIOPSY; ILEUM TISSUE; INFLAMMATION; INTESTINE BIOPSY; INTESTINE FLORA; MALE; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; NONHUMAN; POPULATION ABUNDANCE; PRIORITY JOURNAL; RNA SEQUENCE; SMOKING; SPONDYLARTHRITIS; ACIDAMINOCOCCACEAE; COLON; ILEUM; ISOLATION AND PURIFICATION; MICROBIOLOGY;

COLON; FEMALE; HUMANS; ILEUM; INFLAMMATION; MALE; SPONDYLARTHRITIS; VEILLONELLACEAE;

EID: 85003546086     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39802     Document Type: Article

References (20)

1. Gill T, Asquith M, Rosenbaum JT, Colbert RA. The intestinal microbiome in spondyloarthritis. Curr Opin Rheumatol 2015;27:319–25.
2. Bikel S, Valdez-Lara A, Cornejo-Granados F, Rico K, Canizales-Quinteros S, Soberon X, et al. Combining metagenomics, metatranscriptomics and viromics to explore novel microbial interactions: towards a systems-level understanding of human microbiome. Comput Struct Biotechnol J 2015;13:390–401.
3. Cypers H, Van Praet L, Varkas G, Elewaut D. Relevance of the gut/joint axis for the management of spondyloarthritis in daily clinical practice. Curr Opin Rheumatol 2014;26:371–6.
4. Fava F, Danese S. Intestinal microbiota in inflammatory bowel disease: friend of foe? World J Gastroenterol 2011;17:557–66.
5. Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Fernandez-Sueiro JL, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994;180:2359–64.
6. Lin P, Bach M, Asquith M, Lee AY, Akileswaran L, Stauffer P, et al. HLA-B27 and human β2-microglobulin affect the gut microbiota of transgenic rats. PLoS One 2014;9:e105684.
7. Costello ME, Ciccia F, Willner D, Warrington N, Robinson PC, Gardiner B, et al. Intestinal dysbiosis in ankylosing spondylitis. Arthritis Rheumatol 2015;67:686–91.
8. Dougados M, Simon P, Braun J, Burgos-Vargas R, Maksymowych WP, Sieper J, et al. ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis. Ann Rheum Dis 2011;70:249–51.
9. Apprill A, McNally S, Parsons R, Weber L. Minor revision to V4 region SSU rRNA 806R gene primer greatly increases detection of SAR11 bacterioplankton. Aquat Microb Ecol 2015;75:129–37.
10. Hildebrand F, Tadeo R, Voigt A, Bork P, Raes J. LotuS: an efficient and user-friendly OTU processing pipeline. Microbiome 2014;2:30.
11. McMurdie PJ, Holmes S. Phyloseq: a bioconductor package for handling and analysis of high-throughput phylogenetic sequence data. Pac Symp Biocomput 2012:235–46.
12. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286–91.
13. Lukas C, Landewe R, Sieper J, Dougados M, Davis J, Braun J, et al. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 2009;68:18–24.
14. Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, Bielski C, et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2013;2:e01202.
15. Frank DN, Robertson CE, Hamm CM, Kpadeh Z, Zhang T, Chen H, et al. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 2011;17:179–84.
16. Gevers D, Kugathasan S, Denson LA, Vazquez-Baeza Y, van Treuren W, Ren B, et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 2014;15:382–92.
17. Scher JU, Ubeda C, Artacho A, Attur M, Isaac S, Reddy SM, et al. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol 2015;67:128–39.
18. Stoll ML, Kumar R, Morrow CD, Lefkowitz EJ, Cui X, Genin A, et al. Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis. Arthritis Res Ther 2014;16:486.
19. Joossens M, Huys G, Cnockaert M, de Preter V, Verbeke K, Rutgeerts P, et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 2011;60:631–7.
20. Morio F, Jean-Pierre H, Dubreuil L, Jumas-Bilak E, Calvet L, Mercier G, et al. Antimicrobial susceptibilities and clinical sources of Dialister species. Antimicrob Agents Chemother 2007;51:4498–501.